IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Total liabilities 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) total liabilities at each fiscal year-end, per SEC filings.
$214.6MFY2025 · since FY2016: $5.0M → $214.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $214.6M | +7.3% |
| FY2024 | $200.0M | +2.2% |
| FY2023 | $195.7M | — |
| FY2018 | $14.6M | +47.9% |
| FY2017 | $9.9M | +99.1% |
| FY2016 | $5.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IOVA financial trends
IOVA RevenueIOVA Net incomeIOVA Net marginIOVA Gross profitIOVA Gross marginIOVA Operating incomeIOVA Operating marginIOVA Operating cash flowIOVA Free cash flowIOVA Capital expendituresIOVA Return on equityIOVA Stock buybacksIOVA Dividends paidIOVA Total assetsIOVA Shareholders’ equityIOVA overview →